{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:54:02Z","timestamp":1773834842596,"version":"3.50.1"},"posted":{"date-parts":[[2026,3,18]]},"group-title":"In Review","reference-count":10,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,2,2]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Purpose\n Kidney injury and infectious complications drive much of the morbidity in multiple myeloma (MM)\u2014leading to preventable treatment interruptions and hospitalizations\u2014occurring in up to 50% and 30% of patients, respectively, yet the contribution of alcohol use disorder (AUD) to these core supportive care outcomes is unknown\n                  <sup>1<\/sup>\n                  . Clinicians often suspect that heavy alcohol use worsens tolerance of therapy, but this has rarely been tested in large, real-world datasets.\nMethods\n We performed a retrospective cohort study using the TriNetX Global Health Research Network. Adults with MM (ICD-10 C90\/C90.0) were identified and stratified by the presence of AUD (F10). Propensity score matching (1:1 nearest neighbor) balanced age, sex, race, and ethnicity. Primary supportive care outcomes were acute kidney injury (AKI), chronic kidney disease (CKD), infection, and hematologic toxicities (anemia, neutropenia, thrombocytopenia, venous thromboembolism). Secondary outcomes were diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS).\nResults\n After matching, 12,762 patients (6,381 per group) were included. Compared with matched controls, patients with AUD had higher risks of AKI (35.7% vs 22.7%; risk ratio [RR] 1.57, 95% CI 1.48\u20131.66), CKD (34.0% vs 26.3%; RR 1.30, 95% CI 1.23\u20131.37), infection (32.3% vs 22.3%; RR 1.45, 95% CI 1.36\u20131.54), and hematologic toxicities (57.2% vs 45.4%; RR 1.26, 95% CI 1.22\u20131.30; all p\u2009&lt;\u20090.001)\n                  <sup>2<\/sup>\n                  . Absolute risk increases were 13.0% for AKI (Number Needed to Harm [NNH] 8), 7.7% for CKD (NNH 13), 10.0% for infection (NNH 10), and 11.8% for hematologic toxicities (NNH 8)\n                  <sup>2<\/sup>\n                  . DKA was more frequent in the AUD group (0.8% vs 0.4%, p\u2009=\u20090.004), while HHS did not differ significantly (0.6% vs 0.4%, p\u2009=\u20090.145)\n                  <sup>2<\/sup>\n                  .\nConclusion\n In this large, multi-institutional analysis, AUD was independently associated with clinically important increases in kidney injury, infectious, and hematologic complications in MM. These findings support incorporating structured alcohol screening into MM supportive care pathways to identify patients needing closer monitoring and preventive measures.\n                <\/p>","DOI":"10.21203\/rs.3.rs-8759994\/v1","type":"posted-content","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:49:22Z","timestamp":1773823762000},"source":"Crossref","is-referenced-by-count":0,"title":["Alcohol Use Disorder and Risk of Kidney Injury, Infectious, and Hematologic Complications in Multiple Myeloma: A Real\u2011World Propensity\u2011Matched Cohort Study"],"prefix":"10.21203","author":[{"given":"Syed Emir","family":"Pasha","sequence":"first","affiliation":[{"name":"University of Houston \/ HCA Houston Healthcare Kingwood"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakahn","family":"Haddadin","sequence":"additional","affiliation":[{"name":"MountainView Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Mazharuddin","sequence":"additional","affiliation":[{"name":"Texas Oncology-Kingwood"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Khoury","sequence":"additional","affiliation":[{"name":"Texas Oncology-Kingwood North"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"17","key":"ref1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/archinte.158.17.1889","article-title":"Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients","volume":"158","author":"Blad\u00e9 J","year":"1998","unstructured":"Blad\u00e9 J, Fern\u00e1ndez-Llama P, Bosch F, et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients. Arch Intern Med. 1998;158(17):1889\u20131893.","journal-title":"Arch Intern Med"},{"key":"ref2","article-title":"TriNetX Research Network: Compare Outcomes Analysis Study 3 (MM\/AUD vs MM\/No AUD)","volume":"9","author":"TriNetX","year":"2025","unstructured":"TriNetX. TriNetX Research Network: Compare Outcomes Analysis Study 3 (MM\/AUD vs MM\/No AUD). May 9, 2025.","journal-title":"May"},{"issue":"18","key":"ref3","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle RA","year":"2004","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351(18):1860\u20131873.","journal-title":"N Engl J Med"},{"issue":"31","key":"ref4","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1200\/JCO.2014.58.4680","article-title":"American Society of Clinical Oncology position statement on obesity and cancer","volume":"32","author":"Ligibel JA","year":"2014","unstructured":"Ligibel JA, Alfano CM, Courneya KS, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014;32(31):3568\u20133574.","journal-title":"J Clin Oncol"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.35946\/arcr.v37.2.01","article-title":"Alcohol's effect on host defense","volume":"37","author":"Szabo G","year":"2015","unstructured":"Szabo G, Saha B. Alcohol's effect on host defense. Alcohol Res. 2015;37(2):159\u2013170.","journal-title":"Alcohol Res"},{"issue":"2","key":"ref6","first-page":"F172-F181","article-title":"Chronic alcohol consumption and kidney injury: mechanisms and potential therapeutic targets","volume":"313","author":"Wang Y","year":"2017","unstructured":"Wang Y, Milner E, Yu H, et al. Chronic alcohol consumption and kidney injury: mechanisms and potential therapeutic targets. Am J Physiol Renal Physiol. 2017;313(2):F172-F181.","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref7","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Multiple Myeloma. Version 4.2025. Accessed May 2025."},{"issue":"9596","key":"ref8","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20131457.","journal-title":"Lancet"},{"issue":"9","key":"ref9","first-page":"2034","article-title":"Alcohol and tobacco consumption and risk of multiple myeloma: a prospective study","volume":"17","author":"Birmann BM","year":"2008","unstructured":"Birmann BM, Giovannucci E, Rosner B, et al. Alcohol and tobacco consumption and risk of multiple myeloma: a prospective study. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2034\u20132038.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"ref10","first-page":"705","article-title":"A pooled analysis of alcohol consumption and risk of multiple myeloma in the International Multiple Myeloma Consortium","volume":"37","author":"Andreotti G","year":"2013","unstructured":"Andreotti G, Birmann BM, De Roos AJ, et al. A pooled analysis of alcohol consumption and risk of multiple myeloma in the International Multiple Myeloma Consortium. Cancer Epidemiol. 2013;37(6):705\u2013715.","journal-title":"Cancer Epidemiol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8759994\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8759994\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:49:31Z","timestamp":1773823771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8759994\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":10,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8759994\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,3,18]]},"subtype":"preprint"}}